MyFinsight

HomeBlogAbout

MyFinsight

Making company financials insightful for everyone

  • About
  • Blog
  • Privacy Policy
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

Balance Sheets Overview

Current Ratio
261.66%
Quick Ratio
261.66%
Cash Ratio
7.51%
Debt to Asset Ratio
33.84%
Unit: Dollar
Assets Breakdown
    • Assets of disposal group held-fo...
    • Goodwill
    • Intangible assets, net-Developed...
    • Others
Liabilities Breakdown
    • Additional paid-in capital
    • Accumulated deficit
    • Total mezzanine equity-Series GP...
    • Others
Balance Sheets
2025-09-30
2025-06-30
Cash and cash equivalents
2,517,218
4,474
Accounts receivable
37,490
-
Prepaid expenses
451,879
144,159
Assets of disposal group held-for-sale
83,170,009
83,170,009
Other current assets
1,521,939
-
Total current assets
87,698,535
83,318,642
Property and equipment, net
27,520
-
Intangible assets, net-Developed Technology Rights
18,387,000
-
Intangible assets, net-Customer Relationships
2,630,000
-
Restricted cash
-
7,005
Intangible assets, net-Trade Names
782,000
-
Goodwill
25,796,163
1,684,182
Deposits
49,122
49,122
Total other assets
47,671,805
1,740,309
Total assets
135,370,340
85,058,951
Accounts payable
4,973,285
3,298,447
Accrued expenses
410,324
415,444
Deferred consideration- short term
2,000,000
-
Accrued dividend payable
1,564,753
1,474,009
Line of credit
700,000
700,000
Operating lease liabilities - current
135,609
135,609
Liabilities held-for-sale
23,672,708
23,546,478
Other current liabilities
59,482
105,918
Total current liabilities
33,516,161
29,675,905
Deferred consideration- long term
5,000,000
-
Due to related party
7,292,101
-
Total stockholders' equity (deficit)
-
-6,298,054
Total liabilities
45,808,262
29,675,905
Total mezzanine equity-Series GPreferred Stock
61,681,100
61,681,100
Preferred stock-Series BPreferred Stock
0
0
Preferred stock-Series CPreferred Stock
0
0
Preferred stock-Series DPreferred Stock
0
0
Preferred stock-Series EPreferred Stock
0
0
Preferred stock-Series FPreferred Stock
0
0
Preferred stock-Series HPreferred Stock
4
-
Common stock - par value 0.0001 per share 100,000,000 shares authorized 2,547,147 and 1,584,650 shares issued and outstanding at september 30, 2025 and december 31, 2024, respectively
255
477
Additional paid-in capital
228,392,426
198,347,367
Accumulated deficit
-205,798,707
-204,645,898
Non-controlling interest
5,287,000
-
Total stockholders' equity (deficit)
27,880,978
-
Total liabilities, mezzanine equity and stockholders' equity (deficit)
135,370,340
85,058,951
Unit: Dollar. Numbers labeled with * are estimated quarterly values.

Time Plot

Show the time plot by selecting a row from the table.

Balance Sheets

Assets of disposalgroup held-for-sale$83,170,009 Cash and cashequivalents$2,517,218 Other current assets$1,521,939 Prepaid expenses$451,879 Accounts receivable$37,490 Goodwill$25,796,163 Intangible assets,net-Developed Technology...$18,387,000 Intangible assets,net-Customer Relationships$2,630,000 Intangible assets,net-Trade Names$782,000 Deposits$49,122 Property and equipment,net$27,520 Total current assets$87,698,535 Total other assets$47,671,805 Total assets$135,370,340 Total liabilities,mezzanine equity and...$135,370,340 Total mezzanineequity-Series GPreferred...$61,681,100 Total liabilities$45,808,262 Total stockholders'equity (deficit)$27,880,978 Accumulated deficit-$205,798,707 Total currentliabilities$33,516,161 Due to related party$7,292,101 Deferred consideration-long term$5,000,000 Additional paid-in capital$228,392,426 Non-controlling interest$5,287,000 Common stock - par value0.0001 per share...$255 Preferred stock-SeriesHPreferred Stock$4 Liabilities held-for-sale$23,672,708 Accounts payable$4,973,285 Deferred consideration-short term$2,000,000 Accrued dividendpayable$1,564,753 Line of credit$700,000 Accrued expenses$410,324 Operating leaseliabilities - current$135,609 Other currentliabilities$59,482

Entero Therapeutics, Inc. (ENTO)

Entero Therapeutics, Inc. (ENTO)